Category: General Surgery

Robotic pancreaticoduodenectomy lowers complications and hospital stays

A recent study revealed that robotic pancreaticoduodenectomy (RPD) significantly reduces the rate of clinically relevant pancreatic fistulas (10%) compared to open pancreaticoduodenectomy (OPD) (33.3%). Patients undergoing RPD also experienced shorter hospital stays (15 days) versus 22.5 days for OPD. Despite longer operative times for RPD, overall hospital costs were similar between the two approaches, as […]

Nationwide variation in cholecystitis treatment identified.

A nationwide observational study in the Netherlands aims to investigate treatment variations for cholecystitis across 67 hospitals. Despite existing guidelines, adherence to recommended treatments remains low. The study will assess the percentage of patients receiving early cholecystectomy and identify factors influencing guideline adherence. Researchers will also evaluate the best treatment methods for specific cases and […]

Early mobilization enhances recovery for abdominal cancer surgery patients

Mobilizing patients with abdominal neoplasms within 24 hours post-surgery significantly improved their mobility compared to those receiving standard physiotherapy. Patients in the intervention group displayed higher mobility scores on the ICU Mobility Scale, both initially and at discharge from the ICU, indicating a positive outcome for early mobilization. While both groups experienced a decline in […]

Intersphincteric complex excision improves survival in rectal cancer.

The intersphincteric complex serves as a metastasis niche in ultralow rectal cancer, with 30.96% of patients showing tumor presence in this area. Complete excision of the complex correlates with significantly improved disease-free survival and local recurrence-free survival rates (HR, 0.382; p=0.008 and HR, 0.251; p=0.012, respectively). These findings emphasize the anatomical and prognostic importance of […]

Prophylactic clipping is cost-saving after endoscopic mucosal resection.

A cost-effectiveness analysis involving 4,557 patients found that prophylactic clipping (PC) during endoscopic mucosal resection (EMR) of large non-pedunculated colon polyps is beneficial. For a typical 65-year-old undergoing EMR, PC yielded an incremental cost-effectiveness ratio (ICER) of -$154,706. It proved cost-effective for very large polyps (≥40 mm) and cost-saving for patients on antithrombotic therapy when […]

Intensive Neoadjuvant Chemotherapy Enhances Survival in Pancreatic Cancer

An analysis of 184 patients with anatomically resectable pancreatic cancer and elevated CA19-9 levels demonstrated that those receiving intensive neoadjuvant chemotherapy (NAC) showed significantly improved overall survival compared to those undergoing upfront surgery, with median survival times of 52.7 months versus 22.7 months (p < 0.001). Additionally, higher lymph node-negative resection rates and better post-resection […]

Visual models enhance prediction of rebleeding risk post-EVL

A retrospective study involving 629 patients evaluated rebleeding rates after endoscopic variceal ligation (EVL). Results revealed rebleeding in 34.8% and 80.1% of patients within 6 weeks and 6 months, respectively. Identified factors included esophageal variceal severity and platelet count, both independent risk predictors. Developed visual nomogram models showed high predictive accuracy, with AUCs of 0.942 […]

Multimodal system enhances diagnostic accuracy for hepatic conditions

A deep learning diagnostic system combining CT and ultrasound achieved superior accuracy in detecting hepatic echinococcosis and other liver conditions compared to individual modalities and physician evaluations. The integrated model demonstrated an impressive accuracy of 81.6% in internal tests and 84.9% in external assessments, with high sensitivity and specificity. This innovation significantly reduces misdiagnosis rates, […]

CPLX2 and SNAP25 genes are key in colorectal cancer liver metastasis

CPLX2 and SNAP25 have been identified as significant players in the progression of colorectal cancer liver metastasis. Researchers discovered that these genes are overexpressed in metastatic tissues compared to primary tumors. They also noted that these genes positively regulate the phosphatidylinositol 3-kinase-AKT signaling pathway. Through comprehensive analyses of gene expression and immune infiltration, 1,215 differentially […]

Nivolumab plus ipilimumab improves overall survival in patients

Nivolumab combined with ipilimumab significantly enhances overall survival for patients with untreated unresectable hepatocellular carcinoma compared to lenvatinib or sorafenib. After a median follow-up of 35.2 months, the median overall survival was 23.7 months for nivolumab plus ipilimumab, versus 20.6 months for the other treatments. Although initial higher death rates were observed within the first […]